and cyclophosphamide on the incidence of hemolytic anemia fludarabine lymphocytic leukemia - a beneficial effect of the combination of The prognostic significance of a positive direct antiglobulin test in chronic
暂无分享,去创建一个
[1] T Hamblin,et al. Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial , 2007, The Lancet.
[2] H. Kantarjian,et al. Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab – incidence and predictors , 2007, British journal of haematology.
[3] M. Grever,et al. Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] F. Mandelli,et al. Relationship between autoimmune phenomena and disease stage and therapy in B-cell chronic lymphocytic leukemia. , 2006, Haematologica.
[5] G. Brittinger,et al. Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia. , 2005, Blood.
[6] R. Barker,et al. Rh autoantigen presentation to helper T cells in chronic lymphocytic leukemia by malignant B cells. , 2005, Blood.
[7] S. Schichman,et al. Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma † , 2003, American journal of hematology.
[8] R. Foà,et al. Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features. , 2000, Blood.
[9] V. Leblond,et al. Severe autoimmune hemolytic anemia in eight patients treated with fludarabine. , 1998, Hematology and cell therapy.
[10] J. Byrd,et al. Hemolytic anemia after fludarabine therapy for chronic lymphocytic leukemia. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] L. Diehl,et al. Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia. , 1998, Seminars in oncology.
[12] K. Maloum,et al. Basic biology of autoimmune phenomena in chronic lymphocytic leukemia. , 1998, Seminars in oncology.
[13] M. Błasińska-Morawiec,et al. Autoimmune haemolytic anaemia in patients with chronic lymphocytic eukaemia treated with 2‐chlorodeoxyadenosine (cladribine) , 1997, European journal of haematology.
[14] D. Oscier,et al. Fludarabine‐related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia , 1995, British journal of haematology.
[15] J. Byrd,et al. Fatal recurrence of autoimmune hemolytic anemia following pentostatin therapy in a patient with a history of fludarabine-associated hemolytic anemia. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.
[16] D. Oscier,et al. Autoimmunity in chronic lymphocytic leukaemia. , 1986, Journal of clinical pathology.